StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) operating KPIs

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca tezspire (Amgen alliance) revenue ($M) ($M)

Form 6-K / Form 20-F Alliance Revenue Table

QuarterlyAnnual
Latest, Q2 2026
218
Period ended Jun 30, 2026
Change on a year earlier
+40.6%
155 in Q2 2025
History
13 quarters
Since Q1 2023
Sources
13
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTezspire (Amgen alliance) revenue ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026218+40.6%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 2026154–Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 2025220+65.4%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 2025168+36.6%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 2025155+49.0%Form 6-K FY2025Q2 Earnings Release ↗
Q4 2024Dec 31, 2024133+66.3%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 2024123+66.2%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 2024104+67.7%Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 202477+79.1%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 202380–Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 202374–Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 202362–Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 202343–Form 6-K FY2023Q1 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Tezspire (Amgen alliance) revenue ($M) ($M), quarterly Q1 2023–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/alliance_tezspire

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.